venBio Select Advisor LLC is the SEC registered investment manager for venBio’s long/short equity strategy. We focus principally in securities of publically traded biotechnology companies, and selectively in late-stage private therapeutic companies often in advance of an exit (M&A or IPO). Our investments range from clinical-stage to more mature commercial-stage companies often via direct capital infusion, thereby supporting the advancement of important novel therapies. venBio Select is managed by Dr. Behzad Aghazadeh and supported by a seasoned team with advanced medical and scientific backgrounds, and broad investment experience in the biopharmaceutical sector. The investment and business operations for venBio Select are based in New York.